<<

Western Kentucky University TopSCHOLAR®

Masters Theses & Specialist Projects Graduate School

5-1992 The Ratio of Heinz Body Formation in Different Zurich Subjects Yenya Hu

Follow this and additional works at: http://digitalcommons.wku.edu/theses Part of the Biology Commons, and the Commons

Recommended Citation Hu, Yenya, "The Ratio of Heinz Body Formation in Different Hemoglobin Zurich Subjects" (1992). Masters Theses & Specialist Projects. Paper 1423. http://digitalcommons.wku.edu/theses/1423

This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by an authorized administrator of TopSCHOLAR®. For more information, please contact [email protected]. THE RATIO OF HEINZ BODY FORMATION IN DIFFERENT HEMOGLOBIN ZURICH SUBJECTS

A Th Presen ted To The Faculty of t e Department of Biology Western Kentucky University Bowling Green, Kentucky

In Partial Fulfillment

Of the Requirement for th ~ Degree Master of Science

by Yenya Hu May, 1992 { . "

AUTHORIZATION FOR ~SE OF THESIS

Permission is hereby

granted to the Western Kentucky University Library to make, or allow to be made photocopies, microfilm or other copies of this thesis for appropriate research for scholarly purposes.

reserved to the author for the making of any copies of this thesis except o for brief sections for research or scholarly purposes.

ate: S /i --~~~~------

Please place an "X" in the appropriate box. This form will be filed with the original of the thesis and will control future use of the thesis.

,,*u ...... "-11_ ...... 7 111 THE RATIO OF HEINZ BODY FORMATION IN DIFFERENT HEMOGLOBIN ZURICH PATIENTS

- 7J~L__ ~- =1"--' ~ '-Di~ector of Thesi s

/~a-tJ· /...#- - - -- ~-~------~ ~--

Dean of the Graduate Colle ACKNOWLEDGMENTS

The author wishes to express appreciation to Dr. Martin Houston for his untiring !latience and valuable instructions in supervising this research. Many thanks are also extended to Dr. Frank Toman and Dr. Claire Rinehart for their recommendations. Mrs. Linda Lam is also greatly appreciated. I dedicate this thesis to my fi ance, Xiao Ming, and to my parents. Without their love and support, this research would not have been possible.

III TABLE OF CONTENTS Page

ACKNOWLEDGMENTS ...... 1\1

LIST OF TABLES ...... V . LIST OF FJGURES ...... VI

ABSTRACT ...... , ...... , ...... , .. .. . VII INTRODUCTION ...... 1 MATERIALS AND METHODS ...... 6 RESULTS ...... 8 DISCUSSION ...... 18 LITERATURE CITED ...... 21

IV LIST OF TABLES Page 1. Mean ratios of Heinz body-containing erythrocytes to normal erythrocytes and standard deviations in Hemoglobin Zurich (Hb Zurich) subjects and the control during five weeks ...... 14

2. t values and probability between the Hemoglobin Zurich subjects and the control...... 15 3. A comparison of the ratio of Heinz body-containing erythrocytes to normal erythrocytes between the non-splenectomized Hb Zurich female and the female control during their menstrual cycles ...... 16 4. The ratio of Heinz body-containing erythrocytes to normal erythrocytes of fresh and stored blood ...... 17

v LIST OF FIGURES Page 1. Pedigree chart of the Hemoglobin Zurich family. Abbreviations: S= Splenectomized female Hemoglobin Zurich subject; F= Non­ splenectomized female Hemoglobin Zurich subje~ t; M= Non­ splenectomized male Hemoglobin Zurich subject; C= Female control ...... 5 2. Five-week ratio of Heinz body-containing erythrocytes to normal erythrocytes in the splenectomized subject, the non-splenectomized subjects and the female control. (e Menses) ...... 10 3. Mean ratio of the Heinz body-containing erythrocytes to normal erythrocytes and standard deviation in subjects and the control during five weeks. Abbreviations: S= Splenectomized Hb Zurich female; F= Non-splenectomized Hb Zurich female; M= Non- splenectomized ffi!l.le; C= Female control ...... 11

4. Changes in ratio of Heinz body-con ining erythrocytes to normal erythrocytes in fresh and stored blood. ** Blood stored four months; * blood stored two weeks. Abbreviations: S= Splenectomized Hb Zurich female; F= Non-splenectomized Hb Zurich female; M= Non- splenectomized male; C= Female control...... 12 5. Comparison of five-week ratio of Heinz bodies of a non­ splenectomized female with Hemoglobin Zurich (F) and the normal female control (C). (Menses started in the fou rth weeks) ...... 13

VI .. F if' ~

THE RATIO OF HEINZ BODY FORMATION IN DIFFERENT HEMOGLOBIN ZURICH SUBJECTS

YenyaHu May 1992 22 pages Directed by: Dr. M.R. Houston, Dr. F .R. Toman and Dr. C.A. Rinehart Department of Biology Western Kentucky University

Hemoglobin Zurich is a hemoglobin anomaly that results when one amino acid (histidine) is substituted by arginine at position 63 in the beta chain of hemoglobin molecules [8 63 His---Argl. When Hemoglobirl Zurich individuals are exposed to sulfonamide medication, their denature and subsequently form Heinz bodies which attach to the surface of the plasma membrane. Four Hemoglobin Zurich family members were the subjects of the current study. They included a splenectomized female subject, non­ splenectomized female and male subjects, and a non-splenectomized female member without Hemoglobin Zurich as the control. The results collaborate that increases the n umber of erythrocytes containing Heinz bodies in peripheral blood. The menstrual cycle apparently has no statistical affect on the increased ratio of Heinz body­ containing erythrocytes to normal erythrocytes.

Vll INTRODUCTION

Upon the administration of anti-microbial sulfonamides, patients with Hemoglobin Zurich (Hb Zurich) exhibit severe erythrocytic hemolysis. The abnormal hemoglobin was discovered in Zurich, Switzerland, in 1960 by Hitzig et a!. [1]. Subsequently, other cases were reported in Maryland [2) and Japan [3]. Hb Zurich is the result of a specific genetic mutation [863 His--Arg) in which there is a single amino acid substitution in the beta chain of the hemoglobin molecule [4). The side chain of the distal arginine attaches itself to the propionate of the heme, leaving the heme pocket open,

allowing sulfona ~ ide s access to the iron [5) . Denatured hemoglobins bind tightly to the erythrocytic membrane, often forming dense aggregates on the inner membrane surface termed Heinz bodies. Hemoglobin is denatured by being oxidized initially to methemoglobi . Minor structural rearrangements can lead to formation of a reversible hemichrome which under appropriate conditions can revert back to methemoglobin. Otherwise, the reversible hemichromes denature further to form irreversible hemichro es which eventually aggregate to form Heinz bodies. The rate of hemoglobin denaturation in Hemoglobin Z rich patients is greater than in normal individuals [6]. The abnormal hemoglobin employed in the current study was detected initially by Dr. Alfred Kraus, University of Tennessee Medical School, in 1965. Since Hemoglobin Zurich in this family has not been previously reported in the literature, a summary of the original case report follows. A female patient, approximately two months pregnant, developed a urinary tract infection during the latter part of January, 1965, and was treated with sulfadyne, eight tablets daily, four days continuously. On day four, she

1 2 became jaundiced and then developed aching in the neck, nausea, spots in front of her eyes, and dark urine. On admission to the Baptist Memorial Hospital, Memphis, Tennessee, she was found to have a temperature :> f lOO°F and continued with the low grade fever for the next several days. and autohemolysis tests were performed. The urine was essentially normal. Initial blood analysis resulted in the following: total protein 6.3; albumin 4.3; alkaline phosphatase, 3.0 King-Armscrong units; serine glutamine pyruvate transaminase, 21; cholesterol, 174; bilirubin total, 6.2 mg%, direct, 0.2 mg%; direct , negative. Because of these unusual findings, the following additional laboratory determinations were performed: rapid screening for glucose-6 phosphate dehydrogenase deficiency, normal; lactic acid dehydrogenase electrophoresis. normal; two varieties of hemoglobin: one with the mobility of hemoglobin A and the other with the mobility of hemoglobin S; sickle cell preparation, negative; fetal hemoglobin, 3.5%. Heinz body studies were initiated three days after the blood had been obtained from the patient. The blood was exposed to acetyl phenylhydrazine and stained with brilliant cresyl blue. Numerous Heinz bodies were present in each cell. Peptide mapping and amino acid analysis of the hemoglobin resulted in its identification as Hemoglobin Zurich. Because of severe 3

anemia occurring in the second month of pregnancy, the patient was given several units of packed erythrocytes, and a splenectomy was performed. The was found to be enlal"ged and estimated to be about three times normal size. The pathologist reported that the spleen weighed 150 grams. Microscopic examination showed no specific abnormalities other than some nucleated red cells in the splenic pulp. The rest of the family members were screened for the abnormal hemoglobin with the results shown 10 the pedigree chart, Figure l. Heinz bodies were first described in 1890 by Robert Heinz [7, 8]. They are insoluble, oxidatively denatured hemoglobin which reflects the presence of a metabolic derangement or abnormality in the primary structure of hemoglobin [9]. The principles of their formation and increased hemolysis are: 1) deficiency in one of the reducing systems of blood, ~ glucose-6- phosphate dehydrogenase deficiency; 2) presence of an unstable hemoglobin, such as Hemoglobin Shepherk's Bush, Hemoglobin Gun Hill, Hemoglobin Philly and Hemoglobin Zurich; and 3) exposure to certain chemicals and drugs, .e..JL. sulfonamide medication inducing in people who have a reducing system deficiency and no unstable hemuglobin [10]. Since the spleen removes aged or defective blood cells and platelets from the blood llnd acts as a blood filter, the rate of removal of erythrocytes containing Heinz bodies after a splenectomy will be slower [11]. A study in which erythrocytes containing Reinz bodies were injected into premature infants and adults with and without a splenectomy reported that the rate of removal was decreased after splenectomy [12]. The purpose of this time-course study is to compare the ratio of intra­ erythrocytic Heinz bodies of Hemoglobm Zurich members of the same family utilizing two parameters: splenectomized and non-splenectomized · ..

4

individuals. The course of the study was five weeks. 5

(S) (e)

(M) (F)

Key: Hemoglobin Zurich Individuals

Figure 1. Pedigree chart of the Hemoglobin Zurich family. Abbreviations: S= Splenectomized female Hemoglobin Zurich subject; F= Non­ splenectomized female Hemoglobin Zurich subject; M= Non­ splenectomized male Hemoglobin Zurich subject; C= Female control. MATERIALS AND METHODS Fresh Hemoglobin Zurich blood samples were acquired from the menostasic female subject (S), who was splenectomized in 1965; a non­ splenectomized Hemoglobin Zurich female, (F), who is non-menostasic and the daughter of the subject; a non-Hemoglobin Zurich, non-menostasic female, (C), the sister of S, who was one of the control subjects in tltis study; and a nephew of the individuals S and C, who was the second control,

(Figure 1). Five to 10 ml of blood were drawn on Monday from each per~ on for five continuous weeks by one of the following health facilities: The Medical Center at Bowling Green, Bowling Green Medical Clinic and the Student Health Clinic at Western Kentucky University, Bowling Green, Kentucky. EDTA was the anticoagulant. The erythrocytes were stained with crystal violet obtained from Matheson Coleman and Bell Division, Norwood, Ohio. The blood was examined immediately after drawn, no more than four hours later, with one exception; the male subject's blood drawn on the fourth week was exantined two weeks later. Heinz bodies were stained with crystal violet according to the method of Beutler [12] with the following modification: crystal violet was dissolved in 0.9% (w/v) sodium chloride solution instead of 0.73% (w/v) sodium chloride solution. Crystal violet, 1 g, was added to 50 ml of 0.9% sodium chloride solution, shaken five ntinutes and filtered through mirac1oth, lot 901777, Calbiochem Corporation, La Jolla, California. The filtrate was ntixed with 50 ml of 0.9% sodium chloride solution. The erythrocytic pipetttl was inserted into the edge of the blood, and the blood was allowed to enter to the 0.5 mark on the pipette. The tip of the

6 7 pipette was immediately pl,ce(! in the crystal violet solution until the fluid level reached the 1.01 mark. The pipette was shaken vigorously. and the erythrocytes were stained for five minutes. The cover slip was placed in position over the counting area of a hemacytometer. The pipette was shaken again. The tip was placed exactly at the junction between the cover slip and the chamber. The diluted blood was drawn under the cover slip by capillary action. There were no bubbles present under thll cover slip or fluid present in the moats. The erythrocytes with and without Heinz bodies were counted in eight of the 25 groups of 16 small squares on the hemacytometer. The groups were randomly selected. All erythrocytes were counted which touched the upper and left boundary lines of the squares but not the cells touching the lower and the right boundary lines. The erythrocytes were observed employing a Nikon microscope (43X) from Nikon Inc. Instrument Division. Nippon Kogaka. KK The method of statistics that employed in this time-course study was the t test. RESULTS

Five weeks of data (Figure 2) illustrated that the female subject with a splenectomy had the highest ratio of Heinz body-containing erythrocytes to r.ormal erythrocytes. In the fourth week, the non-splenectomized female Hb Zurich subject had the same ratio as the splenectomized Hb Zurich female subject because of menses. The non-splenectomized female and

male subjects had an intermediate ratio, and the control had the lowe ~ t ratio. Table 1 and Figure 3 contain the mean ratios of the entire five weeks and standard deviations. Compared to the mean ratio of the control, the ratio ()f the female subject with a splenectomy had the highest significant difference. The female and the male subjects had highly significant differences as well (Table 2). Since the female subject with a splenectomy had th e highest ratio of Heinz body-containing erythrocytes to normal erythrocytes and the highest significant difference among the three Hemoglobin Zurich subjects, a comparison of the splenectomized subject and the non-splenectomized subject was made. The results are also shown in Table 2. The ratio of erythrocytes with Heinz bodies of the splenectomized fe male subject and the non-splenectomized female subject still had a significant difference. Thus, the splenectomy had an affect on the ratio of Heinz body-containing erythrocytes to normal erythrocytes. After a splenectomy, the ratio increases. In order to determine if the male and the female subjects had a different ratio, the Heinz body content of erythrocytes from both of the non-splenectomized male and female subjects were studied. There was apparently no significant difference Crable 2 ). During the five-week study, the non-splt: nectomized Hb Zurich female subject was observed to have a monthly jaundice, which was hypothesized 8 , ......

9

to possibly be associated with the menstrual cycle. In the fourth week of the study, the non-splenectomized female subject and the control started their menses on the same day which coincided with the same day blood samples were drawn. Figure 5 shows that both ratios increased. The change between the mean ratio of the first three weeks and ratio of the fourth week in the non-slJlenectomized Hb Zurich female and the female control were almost the same value (Table 3). The data in Table 3 indicate that the menstrual cycle had no specific affect on the increased ratio of Heinz body-containing erythrocytes to normal erythrocytes in the Hemoglobin Zurich subject since the female control had an increased ratio during the menstrual cycle as well (Figure 5). The male subject's blood sample drawn in the second week which had been stored at 4°C, was examined again the fifth week. The ratio of erythrocytes with Heinz bodies of stored blood was the same as fresh blood. The three females' blood that was drawn and had been stored at 4°C for 4 months was re-analyzed. All the ratios of the two female subjects and the control were much higher than originally recorded. Table 4 and Figure 4 contain the results of this experiment. 10

0.2 tID Os I:: 0.18 ·S SOl 0.16 .F I:: E 0.14 8 0 ", .M ,;.,I::~ 0.12 -g.8" Dc .J:J"'o 0.1 ~~l: .- ,,~ 0.08 ~i: Q) ...... c 0.06 o~ 0.04 .S.... Q) ~ 0.02 0 1 2 3 4 5 Weeks

Figure 2. Five-week ratio of Heinz body-containing erythrocytes to normal erythrocytes in the splenectomized subject, the non­ splenectomized Qubjects and the female control (e Menses) 0.2 9 -·-MEAN 0.18 C MEAN.SO

III E 0.16 • MEAN-SO g 0 - 0.14 :il -.i .c~ 0.12 • ~:il 0.1 . c:~ .c~ ~~ $ 0> 0.08

0.06 • f I ·f!w • I 0.04 0 .-2 a:-III 0.02

0

S F M C Individuals

Figure 3. Mean ratio of the Heinz body-containing erythrocytes to normal erythrocytes and standard deviation in subjects and the control during five weeks. Abbreviations: S= Splenectomized Hb Zurich female; F= Non-splenectomized Hb Zurich female; M= Non­ splenectomized Hb Zurich male; C= Female control. 12

0.12 c:.. 'ii .. 0.1 :r Q E c: 0 '0 C c:: :: 0.08 ~CIIO>'- ---~ C U0 o ., ~ 0.06 c: UG>r. - >.>>>.-- U)"U~ 0.04 G) 0 2 f» Q .., r. ..c: ->- 0.02 .s::: ~ t) G> 0 s· . c·· M· Individuals

Figure 4. Changes in ratio of Heinz body-containing erythrocytes to normal erythrocytes in fresh and stored blood .•• Blood stored four months; • blood stored two weeks. Abbreviations: S= Splenectomized Hb Zurich female; F= Non-splenectomized Hb Zurich female; M= Non-splenectomized Hb Zurich male; C= Female control 13

0.18 0 -o-F '" 0.16 ~e 0 C ..c: 0.14 e.", O/O~o c:~ '-' 0.12 0 :g..c:'S e ce. 0.1 8 '" », -os 0.08 ""o S... .s:>o N C 0.06 C .~"' ....,0 :x: 0.04 '-0 0 .~...., 0.02 ~ 0 1 2 3 4 " Weeks

Figure 5. Comparison of five-week ratio of Heinz bodies of a non­ splenectomized female with Hemoglobin Zurich (F) and the normal femRle control (C). (Menses started in the fourth weeks) 14

TABLE 1

Mean ratios of Heinz body-containing erythrocytes to normal erythrocytes and standard deviations in Hemoglobin Zurich (Hb Zurich) subjects and the control during five weeks

Subjects Mean· Standard deviations

Splenectomized female 0.19 0.01 HbZ(S)

Non-splenectomized 0.14 0.02 female Hb Z (F)

Non-splenectomized 0.13 0.01 male Hb Z (M)

Non-splenectomized 0.06 0.02 female control (C)

*(n=5) 15

TABLE 2

t values and probability between the Hemoglobin Zurich subjects and the control

Subjects t values Probability

Splenectomized femRle Hb Zurich vs control (S vs 12.1490 0.001 C)

Splenectomized female Hb Zurich vs non- 3.9680 0.020 splenectomized female Hb Zurich (S vs F) Non-splenectomized female Hb Zurich vs control 5.6022 0.010 (F vs C)

Non-splenectomized male Hb Zurich vs control 6.7698 0.010 (M vs C)

Non-splenectomized female Hb Zurich vs non- 0.8137 0.500 splenectomized male Hb Zurich (F vs M) 16

TABLE 3

A comparison of the ratio of Heinz body-containing erythrocytes to normal erythrocytes between the non-splenectomized Hb Zurich female and the female control during their menstrual cycles

Mean Ratios F* C**

First three weeks (average) 0.130 0.045

Fourth week 0.180 0.090

Difference 0.050 0.045

*F: Non-splenectomized Hb Zurich female subject **C: Female control 17

TABLE 4

The ratio of Heinz body-containing erythrocytes to nonnal erythrocytes of fresh and stored blood

Sample S· F· c· MU Fresh 0.20 0.12 0.04 0.13 Stored 0.29 0.23 0.11 0.13 Ratio differences between 0.09 0.11 0.07 0 fresh and stored samples

S= Splenectomized female Hemoglobin Zurich (Hb Z) F= Non-splenectomized female Hb Z M= Non-splenectomized male Hb Z C= Non-splenectomized female control • Blood was stored four months. ** Blood was stored two weeks. DISCUSSION

The results of true study indicate the existence of a significant difference in the ratio of Heinz bodies to erythrocytes between the three Hb Zurich subjects and the experimental female control. These results indicate that Hemoglobin Zurich is less stable than normal hemoglobin since Heinz bodies are denatured hemoglobin attached to the inner plasma membrane surface. The replacement of the distal rustidine by arginine in Hb Zurich leaves a gap at the entrance to the heme pocket so that sulfonamides and other steric-related oxidants can bind to the heme-iron pocket [6]. Hb Zurich subjects are usually asymptomatic without anemia and severe jaundice unless they are administrated oxidative drugs. especially sulfonamides [3]. During the five-week period. all the subjects and the control were not taking any medication. but Hb Zurich individuals had the higher ratios of Heinz body-containing erythrocytes to normal erythrocytes. According to a study done by Ernesto et al. [7]. the abnormal beta chains in Hb Zurich have an autoxidation rate exceeding those of the normal alpha chains. The difference in the rate of autoxidation between beta-normal and beta­ Hemoglobin Zurich is about 25-fold. The alpha chain of both normal Hemoglobin and Zurich Hemoglobin have very similar rates of autoxidation [8]. Thus. even in the absence of administered sulfonamides. Hb Zurich subjects still contain more Heinz bodies in peripheral blood than in the control. Another reason may be that the rate of blood filtered by the spleen is constant; therefore. the number of Heinz body-containing erythrocytes should increase in peripheral blood when splenic filtration is saturated.

18 19

Also, Heinz body fonnation in cells can be induced by subjecting the cells to oxidative stresses. Thece stresses may arise as part of the body's normal defense mechanism against infection and disease. Firstly, the body temperature could be sufficiently raised to drastically reduce the stability of the hemoglo in and cause it to precipitate as Heinz bodies. Secondly, the oxidants, such as superoxide and H202 produced by phagocytic cells when destroying an infectious agent, could accelerate oxidation and denaturation of the unstable hemoglobin [10]. The ratio of Heinz body-containing erythrocytes to the normal erythrocytes of tI,e splenectomized Hb Zurich subject was statistically significant compared to the other non-splenectomized individuals. The implication is that splenectomy has an effect on the increased number of erythrocytes containing Heinz bodies in peripheral blood. One of the most important functions of the spleen is to remove aged or defective blood cells and platelets from the blood. This function is lost after a splenectomy. Peripheral blood alterations occurring after splenectomy include prompt increase in the number of leucocytes, platelets. immature nucleated erythrocytes and target cells; a tendency toward t inness of the red cells; decreased osmotic fragility; and the appearance of Heinz bodies [l1J. As previously described, the study in which erythrocytes containing denatured hemoglobin were injected intravenously in premature infants and patients following splenectomy. the rate of Heinz body disappearance was slower in splenectomized patients than in control subjects [12J. Both of the non-splenectomized male and female Hb Zurich subjects had a cyclic jaundice. However, it is clear that the cyclic jaundice is apparently not due to the menstrual cycle since it occurs in both the Hb Zurich male and the female. The female control, who still undergoes menses, had an increased ratio of Heinz body-containing erythrocytes to normal erythrocytes during menses as willi. The cyclic jaundice can not be explained at the present time. In conclusion, Hb Zurich subjects had a higher ratio of Heinz body­ containing erythrocytes, and the splenectomized subject had the highest ratio. The menstrual cycle had no effect on the increased ratio of Heinz body-containing erythrocytes to normal erythrocytes of Hb Zurich subjects. There may be a specific cycle of increased Heinz body-formation m peripheral blood for non-splenectomized Hb Zurich subjects. 21

LITERATURE CITED

1. Hitzig, W.H., P.G. Frick and K. Betke. 1960. Hamoglobin Zurich eine niue, hamoglobin-anomalie mit sulfonamidinduzierter innenkorperanamie. Hilvt. Paediat. Acta. 15:499. 2. Dickerman, J .D., N.A. Holtzman and W. H. Zinkham. 1973. Hemoglobin Zurich: A third family presenting with hemolytic reactions to suifonamides. Am..sL Med, 55:638-642. 3. Murate, K., S. Yamamoto, Y. Hirano Mitsuhiro Omine, J. Tsuchiya, Y. Ohba and T. Miyaji. 1982. First Japanese family with the unstable Hemoglobin Zurich [B63(E7) His---Arg]. slaR. sL. Med. 21:140-145. 4. Fairbanks, G., T.L. Steck and D.F.H. Wallach. 1971. Electrophoretic analysis oft-he major polypeptides of the human erythrocyte membrane. Biochemistry. 10:2606-2617.

5. Tucker, P.W., S.E.V. Phillips, M.F. Perutz, R. Houtchens and W.S. Caughey. 1978. Structure of Hemoglobins Zurich [His E7(63) B---Arg] and Sydney [Val E7(67)B---Ala] and the role of the distal residues in ligand binding. Biochemistry, 75:1076-1080. 6. Wangh S.M. and P.S. Low. 1985. Hemichrome binding to band 3: nucleation of Heinz bodies on the erythrocyte membrane. Biochemistry. 24:35-39. 7. Ernesto, E., D. Iorio, K.H. Winterhalter, A. Mansouri, W.E. Blumberg and J. Peisach. 1984. Studies on the oxidation of Hemoglobin Zurich (beta 63 E7 Arg). Eur, sL. Biochem. 145:549-554. 8. Schwab, M.L. and A.E. Lewis. 1969. An improved stain for Heinz bodies. Tech. Bulletin of the Registry of Medical Technologists. 39:93- 95.

9. Jacobs, D. S., B.L. Kasten, Jr., W.R. Demott and W.L. Wolfson. 1988. Hemotology: Laboratory Test Handbook. Ohio: Lexi-CompIMosby. pp.311.

10. Winterbourn, C.C., D.W. Williamson, M.C.M. Vissers and R.W. Carrell. 1984. Unstable Hb haemolytic crises: contributions of pyrexia and neutrophil oxidants. lh:i. sL. Haem, 49:111-116. 11. Miller, D.R. H.A. Pearson, R.L. Baehner and C.W. McMillan. 1978. The spleen and disorders of the reticuloendothelial system: Smith's Blood Diseases of Infancy and Childhood. 4th ed. Missouri: The C.V. Mosby Co. pp.647-649. 12. Acevedo, G. a..'1d A.M. Mauer. 1963. The capacity for removal of erythrocytes containing Heinz bodies in premature infants and patients following spJAnectomy. LPediatr. 63:61-64. 13. Beutler, E. 1955. An in vitro test for sensitivity of erythrocytes to primaquine. sl. Lah. Clin.~· 45:40.